Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CTI-BIOPHARMA-CORP-16603771/news/CTI-BioPharma-Pacritinib-Phase-3-Study-Shows-Positive-Results-In-Patient-Reported-Outcomes-Measuri-20530032/?utm_source=whatsapp&utm_medium=social&utm_campaign=share